A research team at the VIB-KU Leuven Center for Microbiology has developed a novel screening method to identify antimicrobial properties of volatile substances. With this assay, they tested the vapour-phase-mediated activity of 175 essential oils (EOs) and 37 EO components. Approximately half of them proved active against the most drug-resistant type of Candida. In a context of fungi showing increasing drug resistance, these findings may be useful in both medical and agricultural applications.
The research project, led by prof. Patrick Van Dijck, is rooted in the growing problem of antifungal drug resistance. Candida cells, for example, are quickly becoming tolerant to fluconazole, the most-used antifungal drug. Next to exploring experimental new techniques, scientists also seek to repurpose existing substances. Plant essential oils (EOs), metabolites obtained by steam distillation or cold citrus peel pressing, may offer interesting opportunities: they are made up of compounds that help protect the plant against microbial or herbivore attacks.
Identifying EOs and their compounds
In the VIB-KU Leuven Center for Microbiology, Adam Feyaerts gathered a collection of 175 different EOs, constituting a collection of over one thousand different small molecules. The aim was to identify biologically active compounds present in these complex mixtures. They therefore developed a new class of assay that allowed to identify new volatile substances with antifungal activities over a distance.
Prof. Patrick Van Dijck (VIB-KU Leuven): “We screened our whole collection of EOs for vapor-phase mediated antifungal activity against two human fungal pathogens, Candida albicans and Candida glabrata. Interestingly, we found that approximately half of the EOs and their compounds had vapour-phase-mediated activity against bothCandida species. Surprisingly, C. glabrata, the most drug-resistant species of the two was on average even more susceptible. In contrast, none of the currently used antifungals showed any vapour-phase-mediated activity.”
Numerous potential applications
This is now the first simple test to look for the vapor-phase-mediated antimicrobial activity of molecules. The same assay could also be used to test other biological activity. And although these findings still have to be confirmed in clinical trials, potential applications are numerous.
Co-author Adam Feyaerts (VIB-KU Leuven): “Our findings are for instance a starting point for the development of molecules that could also be used in vaporizers. After all, volatiles can access otherwise hard to reach areas. Think of possibilities such as maintaining hygiene in hospitals or treat patients with lung infections. There are agricultural options too, such as preventing post-harvest contamination or protecting crops against pests.”
The Latest on: Antifungal drug resistance
- NovaBiotics given £1.8m to advance Novamycin on February 19, 2019 at 1:51 am
tissue and bloodstream fungal infections caused by difficult to treat and drug resistant moulds and yeasts, including Aspergillus fumigates and Candida auris. Novamycin is highly differentiated from e... […]
- Pharmaceutical group secures £1.8m funding on February 18, 2019 at 11:00 pm
NovaBiotics received the funding to further develop Novamycin, the firm’s first-in-class compound with potential to combat life threatening and drug resistant blood stream and tissue fungal infections ... […]
- Senior Experts from WHO, HPRA, Wellcome Trust, Centauri Therapeutics to present at 21st Annual Superbugs & Superdrugs Conference in 4 weeks’ time on February 18, 2019 at 4:12 am
Q: What role do you believe finding higher quality antifungal hits plays in leading ... Featured Expert-Led Presentations: “The drugs don’t work: WHO’s role in advancing new antibiotics ... […]
- Scynexis: A Novel Antifungal Drug Against Life-Threatening Resistant Infections And Ridiculously Cheap Valuation on February 11, 2019 at 1:48 am
Scynexis recently released impressive data from the open-label FURI trial in invasive candida infections. The stock, which has been slaughtered in the past year, has recovered somewhat but remains ... […]
- Scientists uncover main mechanisms of fluconazole drug resistance on February 11, 2019 at 12:54 am
These infections are usually treated with the drug fluconazole, which inhibits the synthesis ... Morschhäuser's research group has now discovered that resistant fungal cells can quickly switch to sexu... […]
- Fluconazole makes fungi sexually active on February 8, 2019 at 9:07 am
Under the influence of the drug fluconazole, the fungus Candida albicans can ... Morschhäuser's research group has now discovered that resistant fungal cells can quickly switch to sexual reproduction ... […]
- Combating Antifungal Resistance at Superbugs & Superdrugs 2019 on February 8, 2019 at 5:26 am
Excessive use of antifungal agents, coupled with fewer new drugs being developed, is contributing to the accumulation of currently under-recognised multidrug-resistant fungi. The largely neglected ... […]
- The candidiasis drugs market will register a CAGR of almost 4% by 2023 on February 7, 2019 at 2:34 pm
Advances in diagnosis of antifungal resistant pathogens to drive market growth. Although the currently available antifungal drugs are killing various species of candidiasis, some fungi can develop ... […]
- Latest Developments in Combating Antifungal Resistance to be Discussed by Industry Leaders at Superbugs & Superdrugs Conference in London on February 7, 2019 at 12:14 am
... to fight the growing threat of antifungal resistance with industry leaders Meiji Seika Pharma, SCYNEXIS, and Blueberry Therapeutics. Excessive use of antifungal agents, coupled with fewer new drug... […]
- Global Antifungal Drugs Market Growing With CAGR of 3.70% during 2018 – 2023 – Analysis by Drug Class, Therapeutic Indication and Key Regions on February 6, 2019 at 3:07 am
However, growing portfolio of antifungal generic drugs, patent expiration of innovator drugs, increasing prevalence of fungal resistance, and counterfeit drugs are expected to hinder the market perfor... […]
via Google News and Bing News